Europe Hemophilia Treatment Market Research Report Forecast 2017-2021

May 2017 | 135 pages | ID: E578EAAE3B8EN
S&P Consulting

Abstracts

The Europe Hemophilia Treatment Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Hemophilia Treatment industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Hemophilia Treatment market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Hemophilia Treatment Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Pfizer Biotest CSL Behring Kedrion Octapharma Shire Novo Nordisk Bayer F. Hoffmann-La Roche Biogen
company 2
company 3
company 4
company 5
company 6
company 7
company 8
company 9

Europe Hemophilia Treatment Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Hemophilia Treatment Market Analysis by Application:
Hemophilia A Hemophilia B
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 HEMOPHILIA TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Hemophilia Treatment
1.2 Classification of Hemophilia Treatment
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Hemophilia Treatment
  1.3.2 Hemophilia A Hemophilia B
  1.3.3 Application
  1.3.4 Application
1.4 Hemophilia Treatment Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Hemophilia Treatment (2012-2021)
  1.5.1 Europe Hemophilia Treatment Sales and Growth Rate (2012-2021)
  1.5.2 Europe Hemophilia Treatment Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON HEMOPHILIA TREATMENT INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 HEMOPHILIA TREATMENT MANUFACTURING COST ANALYSIS

3.1 Hemophilia Treatment Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Hemophilia Treatment

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Hemophilia Treatment Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Hemophilia Treatment Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE HEMOPHILIA TREATMENT MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Hemophilia Treatment Market Competition by Manufacturers
  5.1.1 Europe Hemophilia Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Hemophilia Treatment Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Hemophilia Treatment (Volume and Value) by Type
  5.2.1 Europe Hemophilia Treatment Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Hemophilia Treatment Revenue and Market Share by Type (2012-2017)
5.3 Europe Hemophilia Treatment (Volume and Value) by Countries
  5.3.1 Europe Hemophilia Treatment Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Hemophilia Treatment Revenue and Market Share by Countries (2012-2017)
5.4 Europe Hemophilia Treatment (Volume) by Application

6 GERMANY HEMOPHILIA TREATMENT (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Hemophilia Treatment Sales and Value (2012-2017)
  6.1.1 Germany Hemophilia Treatment Sales and Growth Rate (2012-2017)
  6.1.2 Germany Hemophilia Treatment Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Hemophilia Treatment Sales Price Trend (2012-2017)
6.2 Germany Hemophilia Treatment Sales and Market Share by Manufacturers
6.3 Germany Hemophilia Treatment Sales and Market Share by Type
6.4 Germany Hemophilia Treatment Sales and Market Share by Application

7 FRANCE HEMOPHILIA TREATMENT (VOLUME, VALUE AND SALES PRICE)

7.1 France Hemophilia Treatment Sales and Value (2012-2017)
  7.1.1 France Hemophilia Treatment Sales and Growth Rate (2012-2017)
  7.1.2 France Hemophilia Treatment Revenue and Growth Rate (2012-2017)
  7.1.3 France Hemophilia Treatment Sales Price Trend (2012-2017)
7.2 France Hemophilia Treatment Sales and Market Share by Manufacturers
7.3 France Hemophilia Treatment Sales and Market Share by Type
7.4 France Hemophilia Treatment Sales and Market Share by Application

8 UK HEMOPHILIA TREATMENT (VOLUME, VALUE AND SALES PRICE)

8.1 UK Hemophilia Treatment Sales and Value (2012-2017)
  8.1.1 UK Hemophilia Treatment Sales and Growth Rate (2012-2017)
  8.1.2 UK Hemophilia Treatment Revenue and Growth Rate (2012-2017)
  8.1.3 UK Hemophilia Treatment Sales Price Trend (2012-2017)
8.2 UK Hemophilia Treatment Sales and Market Share by Manufacturers
8.3 UK Hemophilia Treatment Sales and Market Share by Type
8.4 UK Hemophilia Treatment Sales and Market Share by Application

9 RUSSIA HEMOPHILIA TREATMENT (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Hemophilia Treatment Sales and Value (2012-2017)
  9.1.1 Russia Hemophilia Treatment Sales and Growth Rate (2012-2017)
  9.1.2 Russia Hemophilia Treatment Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Hemophilia Treatment Sales Price Trend (2012-2017)
9.2 Russia Hemophilia Treatment Sales and Market Share by Manufacturers
9.3 Russia Hemophilia Treatment Sales and Market Share by Type
9.4 Russia Hemophilia Treatment Sales and Market Share by Application

10 ITALY HEMOPHILIA TREATMENT (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Hemophilia Treatment Sales and Value (2012-2017)
  10.1.1 Italy Hemophilia Treatment Sales and Growth Rate (2012-2017)
  10.1.2 Italy Hemophilia Treatment Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Hemophilia Treatment Sales Price Trend (2012-2017)
10.2 Italy Hemophilia Treatment Sales and Market Share by Manufacturers
10.3 Italy Hemophilia Treatment Sales and Market Share by Type
10.4 Italy Hemophilia Treatment Sales and Market Share by Application

11 SPAIN HEMOPHILIA TREATMENT (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Hemophilia Treatment Sales and Value (2012-2017)
  11.1.1 Spain Hemophilia Treatment Sales and Growth Rate (2012-2017)
  11.1.2 Spain Hemophilia Treatment Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Hemophilia Treatment Sales Price Trend (2012-2017)
11.2 Spain Hemophilia Treatment Sales and Market Share by Manufacturers
11.3 Spain Hemophilia Treatment Sales and Market Share by Type
11.4 Spain Hemophilia Treatment Sales and Market Share by Application

12 BENELUX HEMOPHILIA TREATMENT (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Hemophilia Treatment Sales and Value (2012-2017)
  12.1.1 Benelux Hemophilia Treatment Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Hemophilia Treatment Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Hemophilia Treatment Sales Price Trend (2012-2017)
12.2 Benelux Hemophilia Treatment Sales and Market Share by Manufacturers
12.3 Benelux Hemophilia Treatment Sales and Market Share by Type
12.4 Benelux Hemophilia Treatment Sales and Market Share by Application

13 EUROPE HEMOPHILIA TREATMENT MANUFACTURERS ANALYSIS

13.1 Pfizer Biotest CSL Behring Kedrion Octapharma Shire Novo Nordisk Bayer F. Hoffmann-La Roche Biogen
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 company
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 company
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 company
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 company
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 company
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 company
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 company
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 company
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE HEMOPHILIA TREATMENT MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Hemophilia Treatment Market Forecast by Type (2017-2021)
15.9 Europe Hemophilia Treatment Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia Treatment
Table Classification of Hemophilia Treatment
Figure Europe Sales Market Share of Hemophilia Treatment by Type in 2015
Table Application of Hemophilia Treatment
Figure Europe Sales Market Share of Hemophilia Treatment by Application in 2015
Figure Germany Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Figure France Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Figure UK Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Figure Russia Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Figure Italy Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Figure Spain Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Figure Benelux Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Figure Europe Hemophilia Treatment Sales and Growth Rate (2012-2021)
Figure Europe Hemophilia Treatment Revenue and Growth Rate (2012-2021)
Table Europe Hemophilia Treatment Sales of Key Manufacturers (2015 and 2016)
Table Europe Hemophilia Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hemophilia Treatment Sales Share by Manufacturers
Figure 2016 Hemophilia Treatment Sales Share by Manufacturers
Table Europe Hemophilia Treatment Revenue by Manufacturers (2015 and 2016)
Table Europe Hemophilia Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Hemophilia Treatment Revenue Share by Manufacturers
Table 2016 Europe Hemophilia Treatment Revenue Share by Manufacturers
Table Europe Hemophilia Treatment Sales and Market Share by Type (2012-2017)
Table Europe Hemophilia Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Hemophilia Treatment by Type (2012-2017)
Figure Europe Hemophilia Treatment Sales Growth Rate by Type (2012-2017)
Table Europe Hemophilia Treatment Revenue and Market Share by Type (2012-2017)
Table Europe Hemophilia Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hemophilia Treatment by Type (2012-2017)
Figure Europe Hemophilia Treatment Revenue Growth Rate by Type (2012-2017)
Table Europe Hemophilia Treatment Sales and Market Share by Countries (2012-2017)
Table Europe Hemophilia Treatment Sales Share by Countries (2012-2017)
Figure Sales Market Share of Hemophilia Treatment by Countries (2012-2017)
Table Europe Hemophilia Treatment Revenue and Market Share by Countries (2012-2017)
Table Europe Hemophilia Treatment Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Hemophilia Treatment by Countries (2012-2017)
Table Europe Hemophilia Treatment Sales and Market Share by Application (2012-2017)
Table Europe Hemophilia Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Hemophilia Treatment by Application (2012-2017)
Figure Germany Hemophilia Treatment Sales and Growth Rate (2012-2017)
Figure Germany Hemophilia Treatment Revenue and Growth Rate (2012-2017)
Figure Germany Hemophilia Treatment Sales Price Trend (2012-2017)
Table Germany Hemophilia Treatment Sales by Manufacturers (2015 and 2016)
Table Germany Hemophilia Treatment Market Share by Manufacturers (2015 and 2016)
Table Germany Hemophilia Treatment Sales by Type (2015 and 2016)
Table Germany Hemophilia Treatment Market Share by Type (2015 and 2016)
Table Germany Hemophilia Treatment Sales by Application (2015 and 2016)
Table Germany Hemophilia Treatment Market Share by Application (2015 and 2016)
Figure France Hemophilia Treatment Sales and Growth Rate (2012-2017)
Figure France Hemophilia Treatment Revenue and Growth Rate (2012-2017)
Figure France Hemophilia Treatment Sales Price Trend (2012-2017)
Table France Hemophilia Treatment Sales by Manufacturers (2015 and 2016)
Table France Hemophilia Treatment Market Share by Manufacturers (2015 and 2016)
Table France Hemophilia Treatment Sales by Type (2015 and 2016)
Table France Hemophilia Treatment Market Share by Type (2015 and 2016)
Table France Hemophilia Treatment Sales by Application (2015 and 2016)
Table France Hemophilia Treatment Market Share by Application (2015 and 2016)
Figure UK Hemophilia Treatment Sales and Growth Rate (2012-2017)
Figure UK Hemophilia Treatment Revenue and Growth Rate (2012-2017)
Figure UK Hemophilia Treatment Sales Price Trend (2012-2017)
Table UK Hemophilia Treatment Sales by Manufacturers (2015 and 2016)
Table UK Hemophilia Treatment Market Share by Manufacturers (2015 and 2016)
Table UK Hemophilia Treatment Sales by Type (2015 and 2016)
Table UK Hemophilia Treatment Market Share by Type (2015 and 2016)
Table UK Hemophilia Treatment Sales by Application (2015 and 2016)
Table UK Hemophilia Treatment Market Share by Application (2015 and 2016)
Figure Russia Hemophilia Treatment Sales and Growth Rate (2012-2017)
Figure Russia Hemophilia Treatment Revenue and Growth Rate (2012-2017)
Figure Russia Hemophilia Treatment Sales Price Trend (2012-2017)
Table Russia Hemophilia Treatment Sales by Manufacturers (2015 and 2016)
Table Russia Hemophilia Treatment Market Share by Manufacturers (2015 and 2016)
Table Russia Hemophilia Treatment Sales by Type (2015 and 2016)
Table Russia Hemophilia Treatment Market Share by Type (2015 and 2016)
Table Russia Hemophilia Treatment Sales by Application (2015 and 2016)
Table Russia Hemophilia Treatment Market Share by Application (2015 and 2016)
Figure Italy Hemophilia Treatment Sales and Growth Rate (2012-2017)
Figure Italy Hemophilia Treatment Revenue and Growth Rate (2012-2017)
Figure Italy Hemophilia Treatment Sales Price Trend (2012-2017)
Table Italy Hemophilia Treatment Sales by Manufacturers (2015 and 2016)
Table Italy Hemophilia Treatment Market Share by Manufacturers (2015 and 2016)
Table Italy Hemophilia Treatment Sales by Type (2015 and 2016)
Table Italy Hemophilia Treatment Market Share by Type (2015 and 2016)
Table Italy Hemophilia Treatment Sales by Application (2015 and 2016)
Table Italy Hemophilia Treatment Market Share by Application (2015 and 2016)
Figure Spain Hemophilia Treatment Sales and Growth Rate (2012-2017)
Figure Spain Hemophilia Treatment Revenue and Growth Rate (2012-2017)
Figure Spain Hemophilia Treatment Sales Price Trend (2012-2017)
Table Spain Hemophilia Treatment Sales by Manufacturers (2015 and 2016)
Table Spain Hemophilia Treatment Market Share by Manufacturers (2015 and 2016)
Table Spain Hemophilia Treatment Sales by Type (2015 and 2016)
Table Spain Hemophilia Treatment Market Share by Type (2015 and 2016)
Table Spain Hemophilia Treatment Sales by Application (2015 and 2016)
Table Spain Hemophilia Treatment Market Share by Application (2015 and 2016)
Figure Benelux Hemophilia Treatment Sales and Growth Rate (2012-2017)
Figure Benelux Hemophilia Treatment Revenue and Growth Rate (2012-2017)
Figure Benelux Hemophilia Treatment Sales Price Trend (2012-2017)
Table Benelux Hemophilia Treatment Sales by Manufacturers (2015 and 2016)
Table Benelux Hemophilia Treatment Market Share by Manufacturers (2015 and 2016)
Table Benelux Hemophilia Treatment Sales by Type (2015 and 2016)
Table Benelux Hemophilia Treatment Market Share by Type (2015 and 2016)
Table Benelux Hemophilia Treatment Sales by Application (2015 and 2016)
Table Benelux Hemophilia Treatment Market Share by Application (2015 and 2016)
Table Pfizer Biotest CSL Behring Kedrion Octapharma Shire Novo Nordisk Bayer F. Hoffmann-La Roche Biogen Basic Information List
Table Pfizer Biotest CSL Behring Kedrion Octapharma Shire Novo Nordisk Bayer F. Hoffmann-La Roche Biogen Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biotest CSL Behring Kedrion Octapharma Shire Novo Nordisk Bayer F. Hoffmann-La Roche Biogen Hemophilia Treatment Sales Market Share (2012-2017)
Table company 2 Basic Information List
Table company 2 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table company 2 Hemophilia Treatment Sales Market Share (2012-2017)
Table company 3 Basic Information List
Table company 3 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 3 Hemophilia Treatment Sales Market Share (2012-2017)
Table company 4 Basic Information List
Table company 4 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table company 4 Hemophilia Treatment Sales Market Share (2012-2017)
Table company 5 Basic Information List
Table company 5 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 5 Hemophilia Treatment Sales Market Share (2012-2017)
Table company 6 Basic Information List
Table company 6 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table company 6 Hemophilia Treatment Sales Market Share (2012-2017)
Table company 7 Basic Information List
Table company 7 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 7 Hemophilia Treatment Sales Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Hemophilia Treatment Sales Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Hemophilia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Hemophilia Treatment Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Treatment
Figure Manufacturing Process Analysis of Hemophilia Treatment
Figure Hemophilia Treatment Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Treatment Major Manufacturers in 2015
Table Major Buyers of Hemophilia Treatment
Table Distributors/Traders List
Figure Germany Hemophilia Treatment Sales and Growth Rate Forecast (2017-2021)
Figure Germany Hemophilia Treatment Revenue and Growth Rate Forecast (2017-2021)
Figure France Hemophilia Treatment Sales and Growth Rate Forecast (2017-2021)
Figure France Hemophilia Treatment Revenue and Growth Rate Forecast (2017-2021)
Figure UK Hemophilia Treatment Sales and Growth Rate Forecast (2017-2021)
Figure UK Hemophilia Treatment Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Hemophilia Treatment Sales and Growth Rate Forecast (2017-2021)
Figure Russia Hemophilia Treatment Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Hemophilia Treatment Sales and Growth Rate Forecast (2017-2021)
Figure Italy Hemophilia Treatment Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Hemophilia Treatment Sales and Growth Rate Forecast (2017-2021)
Figure Spain Hemophilia Treatment Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Hemophilia Treatment Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Hemophilia Treatment Revenue and Growth Rate Forecast (2017-2021)
Table Europe Hemophilia Treatment Sales Forecast by Type (2017-2021)
Table Europe Hemophilia Treatment Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Pfizer
Biotest
CSL Behring
Kedrion
Octapharma
Shire
Novo Nordisk
Bayer
F. Hoffmann-La Roche
Biogen